Auger N, Luu TM, Ayoub A et al (2021) Cannabis-related hospitalizations among Youth in Canada before and after Cannabis Legalization. J Addict Med 15(3):245–247

Article  PubMed  Google Scholar 

Myran DT, Pugliese M, Tanuseputro P et al The association between recreational cannabis legalization, commercialization and cannabis-attributable emergency department visits in Ontario, Canada: an interrupted time–series analysis. Addiction

Yeung MEM, Weaver CG, Janz K et al (2020) Clearing the air: a study of cannabis-related presentations to urban Alberta emergency departments following legalization. Can J Emerg Med 22(6):776–783

Article  Google Scholar 

Koskinen J, Löhönen J, Koponen H et al (2010) Rate of cannabis use disorders in clinical samples of patients with schizophrenia: a meta-analysis. Schizophr Bull 36(6):1115–1130

Article  PubMed  Google Scholar 

Stinson FS, Ruan WJ, Pickering R et al (2006) Cannabis use disorders in the USA: prevalence, correlates and co-morbidity. Psychol Med 36(10):1447–1460

Article  PubMed  Google Scholar 

Statistics Canada (2022) National Cannabis Survey. Ottawa, ON: Government of Canada;https:/http://www23.statcan.gc.ca/imdb/p2SV.pl?Function=getSurvey&SDDS=5262

Lowe DJE, Sasiadek JD, Coles AS et al (2019) Cannabis and mental illness: a review. Eur Arch Psychiatry Clin Neurosci 269(1):107–120

Article  PubMed  Google Scholar 

Brzozowska NI, de Tonnerre EJ, Li KM et al (2017) The Differential Binding of Antipsychotic Drugs to the ABC Transporter P-Glycoprotein Predicts Cannabinoid–Antipsychotic Drug Interactions. Neuropsychopharmacology. ;42(11):2222–2231

Patel R, Wilson R, Jackson R et al (2016) Association of cannabis use with hospital admission and antipsychotic treatment failure in first episode psychosis: an observational study. BMJ Open 6(3):e009888

Article  PubMed  PubMed Central  Google Scholar 

Foglia E, Schoeler T, Klamerus E et al (2017) Cannabis use and adherence to antipsychotic medication: a systematic review and meta-analysis. Psychol Med 47(10):1691–1705

Article  CAS  PubMed  Google Scholar 

Wootten JC, Rodrigues R, Gilliland J et al (2024) The effect of non-medical cannabis retailer proximity on use of mental health services for psychotic disorders in Ontario, Canada. Int J Soc Psychiatry 70(2):308–318

Article  PubMed  Google Scholar 

Ansari H, Jaglal S, Cheung AM et al (2023) Characterization of hip fractures among adults with Schizophrenia in Ontario, Canada. JAMA Netw Open 6(4):e2310550–e2310550

Article  PubMed  PubMed Central  Google Scholar 

Kurdyak P, Lin E, Green D et al (2015) Validation of a population-based algorithm to detect chronic psychotic illness. Can J Psychiatry 60(8):362–368

Article  PubMed  PubMed Central  Google Scholar 

Kim C, Dusing G, Nielsen A et al Disparities in cannabis-related emergency department visits across depressed and non-depressed individuals and the impact of recreational cannabis policy in Ontario, Canada. Psychol Med

Myran DT, Cantor N, Finkelstein Y et al (2022) Unintentional Pediatric Cannabis exposures after legalization of recreational Cannabis in Canada. JAMA Netw Open 5(1):e2142521

Article  PubMed  PubMed Central  Google Scholar 

Kim C, Chum A, Nielsen A et al (2022) Associations between recreational cannabis legalization and cannabis-related emergency department visits by age, gender, and geographic status in Ontario, Canada: an interrupted time series study. PLoS ONE 17(10):e0268718

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kim C, Chum A, Nielsen A et al (2022) Cannabis legalization and cannabis-related hospitalizations in Ontario, Canada. Can J Psychiatry ;07067437221114785

Wang L, Homayra F, Pearce LA et al (2019) Identifying mental health and substance use disorders using emergency department and hospital records: a population-based retrospective cohort study of diagnostic concordance and disease attribution. BMJ Open 9(7):e030530

Article  PubMed  PubMed Central  Google Scholar 

Linden A (2015) Conducting interrupted time-series analysis for single-and multiple-group comparisons. Stata J 15(2):480–500

Article  Google Scholar 

Caulkins JP, Bao Y, Davenport S et al (2018) Big data on a big new market: insights from Washington State’s legal cannabis market. Int J Drug Policy ;5786–5794

Chandra S, Radwan MM, Majumdar CG et al (2019) New trends in cannabis potency in USA and Europe during the last decade (2008–2017). Eur Arch Psychiatry Clin Neurosci 269:5–15

Illinois Recovery Center (2023) Laced Weed: Unveiling the Risks and Realities. Illinois Recovery Centerhttps://www.illinoisrecoverycenter.com/laced-weed/ accessed July 4, 2024)

Hopwood T, Dowd-Green C, Mason M et al (2020) Unintentional use of fentanyl attributed to surreptitious cannabis adulteration. J Am Pharm Assoc 60(6):e370–e374

Article  Google Scholar 

Miller • • S. CT Lab Confirms Marijuana Laced With Fentanyl is a New Public Safety Threat (2021) NBC Connecticuthttp://www.nbcconnecticut.com/news/local/ct-lab-confirms-marijuana-laced-with-fentanyl-is-a-new-public-safety-threat/2658007/ accessed July 4, 2024)

Kourouni I, Mourad B, Khouli H et al (2020) Critical illness secondary to synthetic cannabinoid ingestion. JAMA Netw Open 3(7):e208516–e208516

Article  PubMed  PubMed Central  Google Scholar 

L’Heureux S, Huot-Lavoie M, Bergeron A et al (2024) Effect of cannabis legalization in Canada on the incidence of psychosis consultations in Quebec City’s psychiatric emergency services. Can J Psychiatry ;07067437241232901

Public Health Agency of Canada (2020) Schizophrenia in Canadahttps://www.canada.ca/en/public-health/services/publications/diseases-conditions/schizophrenia-canada.html accessed May 21, 2024)

Callaghan RC, Sanches M, Murray RM et al (2022) Associations between Canada’s cannabis legalization and emergency department presentations for transient cannabis-induced psychosis and schizophrenia conditions: Ontario and Alberta, 2015–2019. Can J Psychiatry 67(8):616–625

Article  PubMed  PubMed Central  Google Scholar